Magyar Kardiológusok Társasága The second edition of the European Cardiology Conference for General Practitioners
Rendezvény kezdete: 2007.10.26.Rendezvény vége: 2007.10.27. Helyszín: Magyarország,1051 Budapest Roosevelt tér 9. Dear Colleague,
After the success of the first conference in December 2006 in Brussels, Belgium, that gathered over 500 General Practitioners from all over Europe, the Program Committee and Chairmen, constituted by Professors Aladár Rónaszéki (Budapest, Hungary), Gilles Montalescot (Paris, France), and Frans Van de Werf (Leuven, Belgium), are pleased to invite you to join the second edition of the European Cardiology Conference for General Practitioners at the Hungarian Academy of Sciences in Budapest, Hungary, from June 1-3, 2007. Kapcsolódó dokumentumok (1)
Magyar Endokrinológiai és Anyagcsere Társaság XIV CAPRI CONFERENCE "Novel Mechanisms and clinical aspects of cardiovascular disorders
Rendezvény kezdete: 2011.04.15.Rendezvény vége: 2011.04.17. Szakterület(ek): Hipertónia, Kardiológia
Tudományos információ: Aristea International Címe: Italy, 00198 Roma, Via Lima, 31 Tel: +39 06 845431 Fax: +39 06 84543700 E-mail: roma@aristea.com Szervező: Aristea International Munkahely neve: Aristea Címe: Italy, 00198 Roma, Via Lima, 31 Tel: +39 06 845431 Fax: +39 06 84543700 E-mail: roma@aristea.com Helyszín: www.capriconference.org, XIV CAPRI CONFERENCE "Novel Mechanisms and clinical aspects of cardiovascular disorders" The Capri Conference is an established and an international event where join together to develop and deal with the multiple and different discoveries that surround the Cardiovascular world.
This year our invited experts will discuss on various issues: from the management of Thromboembolism to the Atrial fibrillation, from new Antiplatelet Agents to Genetic aspects of Cardiomyopathies and to the latest guide line for the treatment of hypertension, heart and kidney.
The following are some of the Hot Topics:
• RAAS and metabolic syndrome
• Antialdosteronic therapy
• Lipids and cv events in the year 2011 – Residual risk
• New advances in the knowledge of renin
• Prevention/protection of MAU in hypertension
• BP targets in hypertension
• RAS and plaque stability
• RAS and vascular remodeling
• AT2 receptor agonists
• Prevention of CV disease in diabetes
• Prorenin/renin receptors